<DOC>
	<DOCNO>NCT00993720</DOCNO>
	<brief_summary>The aim study investigate effect Victoza ( GLP-1 receptor agonist ) insulin-dose , risk hypoglycemia gastric empty rate hypoglycemia patient type 1 diabetes .</brief_summary>
	<brief_title>Effect GLP-1 Insulin-dose , Risk Hypoglycemia Gastric Emptying Rate Patients With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>age 1850y , BMI 1827 , caucasian origin , type 1 diabetes diagnose age 5 age 40 , know diabetes complication cardiovascular disease , medication know influence glucose homeostasis , pregnancy diabetes complication , autonomous nerve dysfunction , anaemia , HbA1c &lt; 8.5 % screening , estimate investigator incapable complete trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>patient type 1 diabetes mellitus</keyword>
</DOC>